Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression

Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression—A Case Report

Published:2021-05 Issue:5 Volume: Page:744-750
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Sheth Hardik¹^ORCID,Kumar Prashant²³⁴,Shreenivas Aditya⁵,Sambath Janani²³,Pragya Ramya¹,Madre Chetan¹,Athikari Nevitha¹,Khandare Hemant¹,Peshattiwar Vishal¹,Datar Rajan⁴,Limaye Sewanti¹^ORCID

Affiliation:

1. Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India

2. Institute of Bioinformatics, Bangalore, India

3. Manipal Academy of Higher Education (MAHE), Manipal, India

4. Department of Research and Innovations, Datar Cancer Genetics Limited, Nasik, India

5. Department of Medical Oncology, Medical College of Wisconsin, Milwaukee, WI

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00436